EPISODE · Feb 11, 2026 · 4 MIN
EP 111.从 23 亿罚单到集采出局，医药财税合规的生死账怎么算
from MedVerse医路人
📉 为什么辉瑞曾面临 23 亿天价罚单？为什么诺华会因合规问题痛失希腊市场？本期播客将以辉瑞、诺华等跨国药企的惨痛教训为切入点，深度揭秘医药财税合规的多米诺骨牌效应。我们不仅探讨虚开发票带来的法律风险，更将算清一笔“经济账”：在融资受阻、集采资格被取消的巨大代价面前，合规投入究竟是成本，还是保命的投资？⚖️ 财税合规的实战避雷针： 从罚款到刑责 隐形代价（Reputation Risk） 集采与准入的入场券 算清经济账关于节目《MedVerse 医路人》是一档聚焦医药行业职业发展、市场与学术推广、以及行业趋势观察的播客。我们希望通过行业解析、案例分享与对话讨论，帮医药人看清职场成长的底层逻辑，找到更清晰的发展路径。找到我们公众号：达维思MedVerse小红书：达利Dali视频号：达维思MedVerse收听渠道：小宇宙、喜马拉雅、苹果Podcast*扣子空间前往小宇宙评论区与主播互动
Embed this episode
NOW PLAYING
EP 111.从 23 亿罚单到集采出局，医药财税合规的生死账怎么算
0:00
4:37
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of MedVerse医路人?
This episode is 4 minutes long.
When was this MedVerse医路人 episode published?
This episode was published on February 11, 2026.
Can I download this MedVerse医路人 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!